Condition: Pseudoxanthoma Elasticum · Tomography, Optical Coherence · Retinal Disease · Sponsor: University Hospital, Angers
This observational study sets out to compare choriocapillaris flow deficits between healthy control subjects and patients with pseudoxanthoma elasticum. Pseudoxanthoma elasticum (PXE) is a rare, incurable hereditary disease caused by genetic mutations. The condition is characterised by excessive tissue mineralisation, which can result in a range of dermatological, vascular, and ophthalmological complications. Among these complications is the potential for visual impairment. The management of this condition is focused on the treatment of its complications. Degeneration of the retina and the choroid (the layer responsible for ensuring its vascularisation) occurs in the eye, resulting in premature degeneration. We would like to study the premature alteration of these structures, which could subsequently be used as an objective marker of the evolution of pseudoxanthoma elasticum.
This description comes directly from the study's public registry record.
Laurie MOUROZEAU, Doctor · +33 (0)2 41 35 32 74 · Laurie.Mourozeau@chu-angers.fr
Matthieu LE LAY, Master · +33 (0)2 41 35 58 91 · DRCI-Promotion-Interne@chu-angers.fr
Always discuss trial participation with your own doctor first.
| Angers University Hospital | Angers, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07006649